FDA Inspection 934266 — Biocon Biologics Limited

Biocon Biologics Limited — FEI 3003981475

The FDA completed an inspection of Biocon Biologics Limited on June 16, 2015 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 16, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)